{"id":19040,"date":"2018-12-12T16:26:56","date_gmt":"2018-12-12T16:26:56","guid":{"rendered":"https:\/\/www.nottinghamtechventures.com\/?post_type=companies&p=19040"},"modified":"2019-01-27T18:46:46","modified_gmt":"2019-01-27T18:46:46","slug":"exonate","status":"publish","type":"companies","link":"https:\/\/www.nottinghamtechventures.com\/companies\/exonate\/","title":{"rendered":"Exonate Ltd"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.<\/p>\n","protected":false},"featured_media":19093,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"sector":[150],"spin_out_name":[166],"acf":[],"yoast_head":"\n